Indoco Remedies Ltd vs Valiant Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 11, 2026

Key Highlights

The Latest Trading Price of Indoco Remedies Ltd is ₹ 228.2 as of 08 May 15:30 . The P/E Ratio of Indoco Remedies Ltd changed from 28.6 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Valiant Laboratories Ltd changed from 2080 on March 2024 to 0 on March 2025 . This represents a CAGR of -100.00% over 2 years The Market Cap of Indoco Remedies Ltd changed from ₹ 2658 crore on March 2021 to ₹ 2152 crore on March 2025 . This represents a CAGR of -4.14% over 5 yearsThe Market Cap of Valiant Laboratories Ltd changed from ₹ 632.63 crore on March 2024 to ₹ 333.65 crore on March 2025 . This represents a CAGR of -27.38% over 2 years The revenue of Indoco Remedies Ltd for the Mar '26 is ₹ 479.31 crore as compare to the Dec '25 revenue of ₹ 446.34 crore. This represent the growth of 7.39% The revenue of Valiant Laboratories Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 53.09 crore. This represent the decline of -100% The ebitda of Indoco Remedies Ltd for the Mar '26 is ₹ 53.41 crore as compare to the Dec '25 ebitda of ₹ 26.34 crore. This represent the growth of 102.77% The ebitda of Valiant Laboratories Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ -0.26 crore. This represent the decline of -100% The net profit of Indoco Remedies Ltd changed from ₹ 1.82 crore to ₹ -23.68 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Valiant Laboratories Ltd changed from ₹ -0.51 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Indoco Remedies Ltd changed from 14.96 % on March 2021 to -21.11 % on March 2025 . This represents a CAGR of NaN% over 5 yearsThe Dividend Payout of Valiant Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Indoco Remedies Ltd

Indoco Remedies Limited, incorporated on August 23, 1947 is a Mumbai-based pharmaceutical company focused on formulations, with some presence in contract manufacturing and research.
The Company headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries.
The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Indoco, a USD 212 million company has 11 manufacturing facilities, 7 of which are for FDFs and 4 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. Currently, Indoco has a presence in therapeutic segments including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and anti-fungal.

About Valiant Laboratories Ltd

Valiant Laboratories Limited was originally formed as a Partnership Firm as M/s.
Bharat Chemicals' through deed of partnership dated October 17, 1980.
The said Partnership Firm, M/s.
Bharat Chemicals thereafter converted into a Public Company to 'Valiant Laboratories Limited' via Certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies. The Company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol.
The Company gradually, commenced manufacturing of Paracetamol by late 1982.

FAQs for the comparison of Indoco Remedies Ltd and Valiant Laboratories Ltd

Which company has a larger market capitalization, Indoco Remedies Ltd or Valiant Laboratories Ltd?

Market cap of Indoco Remedies Ltd is 2,106 Cr while Market cap of Valiant Laboratories Ltd is 441 Cr

What are the key factors driving the stock performance of Indoco Remedies Ltd and Valiant Laboratories Ltd?

The stock performance of Indoco Remedies Ltd and Valiant Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indoco Remedies Ltd and Valiant Laboratories Ltd?

As of May 11, 2026, the Indoco Remedies Ltd stock price is INR ₹228.2. On the other hand, Valiant Laboratories Ltd stock price is INR ₹81.25.

How do dividend payouts of Indoco Remedies Ltd and Valiant Laboratories Ltd compare?

To compare the dividend payouts of Indoco Remedies Ltd and Valiant Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.